Unexpectedly, MAPK pathway activation were shown to be associated with long HNSCC patient survival, probably via abrogating ErbB3 activation, a well-established progression signal in HNSCC [95]. This evidence concerns the gene ERBB3 and head and neck squamous cell carcinoma.